Process Development and Manufacturing of Blood Proteins
Discover our Technologies for Plasma Fractionation and Recombinant Blood Factors
The global demand for blood proteins is expanding due to new indications, better access and an aging population. Plasma fractionating companies adapt to this strongly growing market demand by maximizing their facility throughput and by making their facilities more flexible. In addition, yield optimization and process characterization is increasingly important. Product diversification such as recombinant processes open new possibilities with regard to new indications and help to satisfy the increasing market demand.